LRF Clinical Investigator Career Development Award 2027: $225,000 Over Three Years for Early-Career Lymphoma Physician-Scientists

LRF Clinical Investigator Career Development Award 2027: $225,000 Over Three Years for Early-Career Lymphoma Physician-Scientists

The Lymphoma Research Foundation (LRF) Clinical Investigator Career Development Award (CDA) is one of the most practical grants available to a physician who has finished clinical training and wants to build a research career focused on lymphoma. It answers the question that stalls so many promising clinician-scientists at exactly this stage: how do you protect enough time for research when clinical service, teaching, and administrative duties keep expanding? The CDA does that directly, with $225,000 of committed support over three years, tied to a requirement that the awardee spend a meaningful share of their week on independent lymphoma research under the guidance of an institutional mentor.

LRF has confirmed that the CDA is part of its 2027 Early Career Grant slate, alongside the Postdoctoral Fellowship Grant and the Lymphoma Scientific Research Mentoring Program (LSRMP). For the 2027 cycle, applicants who submit a full application are notified in writing in December 2026, and grants carry an earliest start date of March 1, 2027 with a latest start date of July 1, 2027. That timeline makes this a live opportunity to plan for now, not a closed cycle to monitor for next year.

This guide explains what the award funds, who fits, how the money is structured, what the review panel looks for, and how to put together an application that reads like the beginning of an independent research program rather than a well-written wish list.

Key Details at a Glance

Confirm the exact 2027 Letter of Intent and full-application deadlines against the official request for proposals (RFP) on the LRF grants page before you build your submission calendar. Historically the full application has been due in early September, but each cycle’s dates are set in the posted RFP.

What the Award Offers

The CDA delivers $225,000 across three years, budgeted at $75,000 per year. Of that annual amount, $70,000 is salary support and up to $5,000 may be budgeted for research supplies or professional development expenses such as conference travel and coursework. The salary emphasis is deliberate. This is a career development award, not a project grant: its central purpose is to buy protected research time for a physician who could otherwise be pulled entirely into clinical work.

That structure has two consequences worth understanding early. First, the money is meant to underwrite your effort, so the application must credibly show that your institution will honor the protected time and that your clinical and administrative load will leave room for it. Second, because the direct research-expense budget is modest, strong applications usually pair the CDA with existing laboratory resources, mentor infrastructure, shared cores, or a project whose costs are proportionate to a developing investigator rather than a fully staffed lab.

The award is also a credential. An LRF CDA on your record signals to departments, promotion committees, and future funders that a national, disease-focused foundation reviewed your plan and judged you a good bet for independence. For many recipients, the tangible value of that signal — in negotiating a faculty position, protected time, or startup support — rivals the cash itself.

Who Should Apply

The CDA is built for physician investigators at the level of advanced fellow or junior faculty member who intend to contribute to new lymphoma therapies and diagnostic tools. The defining eligibility line is experience: applicants should have no more than five years of experience beyond completion of their clinical fellowship or postdoctoral training. LRF has historically allowed that five-year window to be counted non-sequentially in documented cases such as pregnancy or illness, which matters for anyone whose training timeline was interrupted.

Two other expectations sit at the center of eligibility. You must be prepared to spend at least 35 percent of your time on independent clinical research, and you must have an institutional mentor who will support that work. The mentor requirement is not a formality; the review panel weighs the quality of the mentoring environment heavily because a career development award is a bet on trajectory, and trajectory depends on institutional backing.

The award fits best if you can point to a specific lymphoma research question, a mentor and setting equipped to help you pursue it, and a realistic plan for what independence looks like at the end of three years. It fits poorly if lymphoma is only a peripheral interest, if your protected time is aspirational rather than committed, or if you are already running an independent, well-funded laboratory — at which point other mechanisms suit you better.

LRF also reserves a minimum of one CDA for a project that focuses on underrepresented patient populations and/or for an applicant who is a member of an underrepresented group. If your work addresses disparities in lymphoma outcomes, access, or representation in research, say so clearly and let the science speak to that commitment.

Eligibility Requirements in Detail

Before you invest time in a full application, check each requirement against your own situation:

• Degree and role: You are a physician investigator functioning as an advanced fellow or junior faculty member.
• Experience window: You are within five years of completing clinical fellowship or postdoctoral training, with allowance for documented interruptions.
• Research focus: Your proposed work is squarely in lymphoma, aimed at advancing therapies or diagnostic tools.
• Effort commitment: You can commit at least 35 percent of your time to independent clinical research for the duration of the award.
• Mentorship: You have an institutional mentor prepared to support your development, and an environment with the resources your project needs.
• Institutional support: Your institution will formalize the protected time and administer the grant.

Because eligibility and administrative policies are set precisely in each year’s RFP and accompanying policy document, read the 2027 documents in full on the official LRF grants page rather than relying on summaries. Details such as citizenship or institution-location rules, allowable concurrent funding, and budget restrictions can change between cycles and are the kind of thing that quietly disqualifies an otherwise strong application.

Application Process and Timeline

LRF runs its early-career grants on an annual cycle. For 2027, applicants who submit a full application will be notified of decisions in writing in December 2026, and funded grants will start between March 1, 2027 and July 1, 2027. Working backward from a December notification, the full application has historically been due in early September, so plan for a late-summer submission and confirm the exact date on the posted RFP.

A realistic path looks like this:

1. Read the 2027 RFP and policy document. Download both from the LRF grants page as soon as they are posted. Note the Letter of Intent step if one is required, the full-application deadline, budget rules, and required attachments.
2. Confirm institutional support early. Protected time, mentor commitment, and grants-office signoff take longer than applicants expect. Start these conversations weeks before the deadline.
3. Draft the research plan. Frame a focused, feasible lymphoma project that a developing investigator can realistically drive with the resources described.
4. Assemble mentor and institutional letters. These should speak concretely to your protected time, the environment, and your readiness for independence.
5. Build the budget. Allocate the $70,000 salary support and up to $5,000 incidental funds per year in line with RFP rules.
6. Submit through LRF’s online system ahead of the deadline, leaving room for upload or signature problems.

Give yourself a buffer of at least a week before the stated deadline. Foundation portals, like all grant portals, are busiest in the final hours, and a missed institutional signature is a common, avoidable reason applications fail to submit.

Preparing a Competitive Application

The strongest CDA applications read as the first chapter of an independent research career. Reviewers are asking a forward-looking question: will this person, with three years of protected time and mentorship, become an independent lymphoma investigator? Everything in your application should build toward a confident “yes.”

Anchor the proposal in a specific, answerable lymphoma question. A tightly scoped project that you can realistically complete — and publish — in three years beats an ambitious program that reads as unfinishable on a modest budget. Make the significance concrete: explain what changes for lymphoma patients or for the field if your work succeeds, without inflating claims.

Treat the mentorship and environment sections as core science, not paperwork. Name what the mentor and institution provide — expertise, samples, cores, patient populations, complementary funding — and how those resources make your plan feasible. A well-documented environment reassures reviewers that your protected time will translate into results.

Be explicit and honest about the 35 percent effort commitment. Show, with an institutional letter, that the time is genuinely carved out. Reviewers have seen protected time evaporate under clinical demands; concrete institutional commitments distinguish credible plans from optimistic ones.

If your work addresses underrepresented patient populations or you are a member of an underrepresented group, present that clearly and let it strengthen the scientific case. LRF’s reserved CDA reflects a genuine priority, and a project that advances equity in lymphoma research speaks directly to the Foundation’s mission.

Common Mistakes to Avoid

• Treating it like a project grant. The CDA funds your development. Applications that read as pure project proposals, with no attention to career trajectory and mentorship, miss the point of the mechanism.
• Vague protected time. Saying you will spend at least 35 percent of your time on research without an institutional letter that guarantees it undercuts your credibility.
• Overscoping the science. A three-year, modest-budget award cannot support an open-ended program. Reviewers reward feasibility.
• Thin mentorship detail. A generic mentor letter signals a weak environment. Specific, resource-backed commitments signal a strong one.
• Ignoring the RFP fine print. Eligibility windows, budget caps, and administrative rules are set precisely in each year’s documents. Skipping them is how strong candidates get ruled ineligible on technicalities.
• Submitting at the last minute. Institutional signoff and portal uploads fail at the worst possible time. Build in a buffer.

Frequently Asked Questions

How much is the award and how is it paid? The CDA provides $225,000 over three years, budgeted at $75,000 per year — $70,000 in salary support and up to $5,000 in incidental funds for research supplies or professional development.

Who is eligible? Physician investigators at the advanced-fellow or junior-faculty level, within five years of completing clinical fellowship or postdoctoral training, who will commit at least 35 percent of their time to independent clinical lymphoma research with an institutional mentor.

Is the five-year experience limit strict? LRF has historically allowed the window to be counted non-sequentially in documented situations such as pregnancy or illness. Confirm the current policy in the 2027 RFP.

When is the deadline for the 2027 cycle? LRF notifies full-application submitters in December 2026, with grants starting between March 1 and July 1, 2027. The full application has historically been due in early September; verify the exact 2027 date on the official grants page.

Does the award prioritize equity? Yes. At least one CDA is reserved for a project focused on underrepresented patient populations and/or an applicant who is a member of an underrepresented group.

Where do I apply? Through the Lymphoma Research Foundation’s grants system. Start from the Current Grant Opportunities page and download the 2027 CDA RFP and policy document.

Official Links and Next Steps

Begin at the Lymphoma Research Foundation’s grant opportunities page: https://lymphoma.org/researchers/grants/. There you can access the 2027 RFP and policy documents for the Clinical Investigator Career Development Award and the Foundation’s other early-career programs, and subscribe to be notified when new RFPs are released.

Your practical next steps: confirm you fall within the five-year experience window, secure a mentor and an institutional commitment for protected time, and outline a focused lymphoma research question you can advance over three years. Then read the 2027 RFP in full, mark the confirmed deadlines on your calendar, and give yourself weeks — not days — to assemble institutional letters and signatures. A CDA is competitive, but it rewards exactly the candidate it was designed for: a physician with real clinical insight, a specific research idea, and an institution ready to help them become independent.